Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 3 (4) , 377-386
- https://doi.org/10.1016/s1535-6108(03)00058-8
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma CellsPublished by Elsevier ,2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The role of extracellular matrix in small-cell lung cancerThe Lancet Oncology, 2001
- Biglycan and Decorin Bind Close to the N-terminal Region of the Collagen VI Triple HelixPublished by Elsevier ,2001
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Serial Analysis of Gene ExpressionScience, 1995
- Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinomaInternational Journal of Cancer, 1994
- Recombinant expression and properties of the Kunitz‐type protease‐inhibitor module from human type VI collagen α3(VI) chainEuropean Journal of Biochemistry, 1994
- Integrin and Arg-Gly-Asp Dependence of Cell Adhesion to the Native and Unfolded Triple Helix of Collagen Type VIExperimental Cell Research, 1993
- Cell contact as a possible contribution to radiation resistance of some tumoursThe British Journal of Radiology, 1972